These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 3111251)

  • 1. Altered von Willebrand factor molecule in children with thrombosis following asparaginase-prednisone-vincristine therapy for leukemia.
    Pui CH; Chesney CM; Weed J; Jackson CW
    J Clin Oncol; 1985 Sep; 3(9):1266-72. PubMed ID: 3875694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIII/von Willebrand factor abnormalities during L-asparaginase treatment in patients with acute lymphoblastic leukemia.
    Casonato A; Lazzaro AR; Rosolen A; Girolami A
    Acta Haematol; 1988; 80(4):190-3. PubMed ID: 3146197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies.
    Charba D; Moake JL; Harris MA; Hester JP
    Am J Hematol; 1993 Mar; 42(3):268-77. PubMed ID: 8438900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
    Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
    Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of acute lymphoblastic leukemia in childhood.
    Mauer AM
    Blood; 1980 Jul; 56(1):1-10. PubMed ID: 6992886
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of von Willebrand factor in thrombosis following asparaginase-prednisone-vincristine therapy for leukemia.
    Pui CH; Jackson CW; Chesney CM; Abildgaard CF
    Am J Hematol; 1987 Jul; 25(3):291-8. PubMed ID: 3111251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
    Yoshioka A
    Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.